|
|
Article: India : Caraco looking at shifting production to India.
- Article from:
- TendersInfo
- Article date:
- November 2, 2009
CopyrightCOPYRIGHT 2009 Al Bawaba (Middle East) Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Byline: pinto03
Sun Pharmaceutical Industries US -based subsidiary, Caraco, which is facing a Food and Drug Administration (FDA) ban on manufacturing, is looking at shifting production of some of the drugs to India.
The company will, however, remain focused on addressing the issues related to manufacturing and compliance raised by the FDA, Caraco CEO Jitendra N Doshi said in its annual report.
Doshi said Caraco was also considering selling some of its products, made by third party manufacturers, through some other facility, including its parent company, Sun Pharma.
Dilip Shanghvi We may also transfer certain manufactured products to an ...